Close

Berry’s New India Facility Starts to Take Shape for Growing Healthcare Market

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

WHO Supplies Medical Equipment for Post-Marburg Virus Heal

In a recent move, the World Health Organization has...

Life Sciences Sector Plan Sets UK on Global Growth Track

Main Article: UK Life Sciences Sector Plan Sets Sights...

UK Government Launches Ambitious Life Sciences Sector Plan

Government Unveils Life Sciences Roadmap for Growth and Innovation London,...

Highly Customized Treatments to Offer Specialized Care to UK

The Human Medicines Regulations 2025, which came into force...

Berry Global has begun construction of its new manufacturing facility and global Centre of Excellence in India.

Based in Sira, close to the company’s existing operation in Bangalore, the new factory will offer world-class capabilities to serve the healthcare and other key market sectors. It will enable Berry to extend its R&D innovation expertise and scale up production to support growing demand from customers throughout India and South Asia, offering best in class quality and service to both national and international businesses, as well as local and start-up companies.

In particular, the site will have International Sustainability and Carbon Certificate (ISCC) Plus accreditation. This enables it to sell to healthcare customers certified packaging and plastic components that contribute to a circular economy approach, based on advanced recycling and mass balance. Mass balance is an accepted chain of custody methodology that documents and tracks recycled and/or biobased content from supplier through to final delivery to customers.

The Sira facility will consolidate Berry’s leading position in the design, development and production of patient-centred healthcare solutions, including ophthalmic, nasal pumps, inhalation, and injectable administrations. Central to this are the company’s technical and design skills in the creation of products that improve the patient experience for the administration of medicines and ensure the highest levels of functionality in areas such as ease of use, dosage control, and effective medicine protection, while also helping to meet customers’ sustainability goals.

The manufacturing facility will house the latest precision high-quality manufacturing equipment along with a dedicated R&D Centre of Excellence to support the design and development of new products and customer-specific projects.

“This latest investment demonstrates our commitment to establish strategically-placed facilities throughout the world that will enable us to bring our global expertise and localised support to customers of any size,” commented Jean-Marc Galvez, President, Consumer Packaging International (CPI) Division. “It will allow us to further strengthen existing customer partnerships and develop new business opportunities in this important region.”

Construction of the 15-acre site began with the traditional Pooja ceremony and the laying of the foundation stone. Building work is now in progress with the clean room expected to be operational by the end of this year and full completion of the factory by Spring 2023.

Latest stories

Related stories

WHO Supplies Medical Equipment for Post-Marburg Virus Heal

In a recent move, the World Health Organization has...

Life Sciences Sector Plan Sets UK on Global Growth Track

Main Article: UK Life Sciences Sector Plan Sets Sights...

UK Government Launches Ambitious Life Sciences Sector Plan

Government Unveils Life Sciences Roadmap for Growth and Innovation London,...

Highly Customized Treatments to Offer Specialized Care to UK

The Human Medicines Regulations 2025, which came into force...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back